Vera Therapeutics, Inc. (VERA)
34.19
-0.41
(-1.18%)
USD |
NASDAQ |
Aug 28, 16:00
34.22
+0.03
(+0.09%)
After-Hours: 20:00
Vera Therapeutics Total Liabilities (Quarterly) : 125.23M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.23M |
| March 31, 2026 | 122.04M |
| December 31, 2025 | 130.78M |
| September 30, 2025 | 118.62M |
| June 30, 2025 | 110.25M |
| March 31, 2025 | 75.17M |
| December 31, 2024 | 79.32M |
| September 30, 2024 | 79.50M |
| June 30, 2024 | 69.42M |
| March 31, 2024 | 65.81M |
| December 31, 2023 | 73.86M |
| September 30, 2023 | 51.91M |
| Date | Value |
|---|---|
| June 30, 2023 | 54.66M |
| March 31, 2023 | 51.90M |
| December 31, 2022 | 54.53M |
| September 30, 2022 | 25.65M |
| June 30, 2022 | 27.28M |
| March 31, 2022 | 30.55M |
| December 31, 2021 | 14.16M |
| September 30, 2021 | 5.69M |
| June 30, 2021 | 5.492M |
| March 31, 2021 | 5.565M |
| December 31, 2020 | 4.326M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 532.98M |
| Shareholders Equity (Quarterly) | 407.76M |
| Debt to Equity Ratio | 0.1845 |
| Current Ratio | 10.65 |
| Net Debt Paydown Yield | -0.13% |